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new chemical policy under consideration by the European
Union (EU) will, if implemented, initiate a significant
change in the way industrial chemicals are regulated in
the world’s second largest economy. It will be the most compre-
hensive such policy in the world, and it will not only affect all the
countries and industries that do business in the EU, but may also
prompt changes in other nations’ chemical policies. The propos-
al—Registration, Evaluation, and Authorisation of Chemicals
(REACH)—will be introduced in the European Parliament late
this year. If it passes in its current form, the new REACH require-
ments will be phased in over about a decade, first handling the
most dangerous chemicals and so-called high production volume
(HPV) chemicals, those produced or imported at volumes above
1,000 metric tons annually.
The European Commission (EC), which is the executive
branch of the EU, began developing REACH in 1998. In
February 2001 the EC adopted a white paper, “Strategy for a
Future Chemicals Policy,” detailing the proposed system. Since
then, interested parties, including the global chemical industry,
environmental nongovernmental organizations (NGOs), and
other governments (particularly the U.S. government) have been
weighing in on REACH’s pros and cons. Nearly every provision
of REACH is the subject of intense debate and lobbying. 
Much is at stake. The chemical industry is among the biggest of
big businesses worldwide. According to the white paper, world pro-
duction of chemicals has mushroomed from 1 million metric tons in
1930 to 400 million metric tons today. The European Chemical
Industry Council states that in 1999 world sales of chemicals totaled
US$1.6 trillion, with the EU accounting for 29%, or US$474 bil-
lion. Another 2% is generated by non-EU European countries, mak-
ing Western Europe the world’s leading producer of industrial
chemicals. About 3 million jobs in the EU depend on chemical
manufacturing and related businesses. The U.S. chemical industry
ranks second, producing 27%, or US$484 billion, of world output
in 1999. According to the U.S. Chamber of Commerce, American
companies export upwards of US$20 billion in chemicals to Europe
every year, along with US$400 billion in downstream products.
Historic Precedent
In the EU, as in the United States, chemical regulation has been
based on historic precedent. Chemicals on the market in the EU
before 1981 were “grandfathered”—that is, they could continue
to be used without testing to prove that they were safe for humans
and the environment. Since 1981, only about 2,700 new sub-
stances have entered the market, according to the white paper.
However, of the approximately 100,000 substances listed in the
European Inventory of Existing Commercial Chemical
Substances, a database maintained by the EC, some 80,000 are
thought to be currently in use in the EU. Thus, the vast majority
of chemicals now in use have undergone no risk or hazard assess-
ments. Further, according to the white paper, 70% of the 2,700
new chemicals introduced in the EU since 1981 have been found
to be “dangerous” as defined by EU Directive 67/548, under
which chemicals are considered dangerous if they are corrosive,
flammable, mutagenic, carcinogenic, developmentally or other-
wise toxic, irritating, or sensitizing.
The United States is in a similar state of ignorance. The April
1998 Environmental Protection Agency (EPA) Chemical Hazard
Data Availability Study revealed that although nearly 3,000 chem-
icals have HPV status in the United States (defined by the EPA as
imported or produced at 1 million pounds per year), complete
basic toxicity profiles (covering acute, subchronic, chronic, devel-
opmental, and reproductive toxicity, as well as mutagenicity) were
available for only 7% of these. 
This problem has been recognized for years, and efforts to
gather and organize chemical hazard and risk information are
under way at many levels, says Lesley Onyon, a scientist with the
World Health Organization’s International Programme on
Chemical Safety (IPCS). Because of widespread concern about the
amount of animal testing that might be necessary to fill all the
gaps in chemical hazard and risk information, Onyon says, the
IPCS is working to gather “existing information about the hazards
of chemicals that is currently not being used”—such as the “obser-
vational human data generated through routine clinical and occu-
pational health and safety practice”—and to improve access to
that information. 
The Organisation for Economic Co-operation and
Development (OECD), a group of 30 industrialized nations
including all EU member countries and the United States, is the
foremost player in efforts to deal internationally with the limited
data on chemicals. The OECD has developed extensive chemical
testing guidelines and is assessing 1,500 HPV chemicals (with
HPV defined here as over 1,000 metric tons per year) with the
voluntary participation of the chemical industry. And the U.S.
EPA is developing a Screening Information Data Set that
includes acute toxicity, chronic toxicity, developmental and
reproductive toxicity, mutagenicity, ecotoxicity, and environ-
mental fate information for the 3,000 HPV chemicals in use in
the United States. The EPA is also conducting the Voluntary
Children’s Chemical Evaluation Program, in which manufactur-
ers of 23 chemicals (including benzene, trichloroethylene, and
ethylene dichloride) are evaluating the health risks to children of
exposure to these chemicals.
REACH’s Provisions
REACH will replace 40 different EU-level regulations and will
apply to both domestically manufactured and imported chemicals,
and, to a lesser extent, to those products made from them that
expose humans or the environment to chemicals of concern. Prior
to REACH, governments have been responsible for determining
chemicals’ toxicity, mutagenicity, potential for endocrine disrup-
tion, carcinogenicity, persistence, and bioaccumulation, as well as
the degree and likelihood of exposure to humans and the environ-
ment. Under REACH, the burden of proof of a chemical’s safety
is transferred primarily to manufacturers. If a chemical is used in a
way unanticipated by the manufacturer, downstream users such as
computer makers, paint formulators, and textile importers will
have to show proof of safety. 
REACH requires registration of all chemicals marketed at
annual volumes above 1 metric ton per manufacturer or importer;
this is estimated to be 30,000 substances. Because of their low
production volume, about 80% of these would require no further
action. Chemicals produced in volumes above 100 metric tons per
year require evaluation, including review of animal testing data,
by member state experts and a new EU chemicals agency, which
will be enabled by the passage of REACH. Chemicals termed
“substances of very high concern”—carcinogens, mutagens, repro-
ductive toxicants, and those that are persistent or bioaccumulative
(including endocrine disruptors and persistent organic pollu-
tants)—will require authorization for each contemplated use. The
EU white paper estimates there are about 1,400 of these chemi-
cals. Some chemicals may be banned altogether. 
REACH explicitly invokes the precautionary principle—that
when scientific evidence suggests a substance may harm human
health or the environment but the type or magnitude of harm is
not yet known, it is preferable not to use the substance until the
scientific questions are resolved. It also encourages, but does not
require, the substitution of less hazardous chemicals if available,
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Pand aims to reduce the number of animals
used in testing whenever possible by
applying quantitative modeling tech-
niques and accepting in vitro data and
certain existing test results rather than
requiring entirely new tests. Data sharing
along the supply chain is encouraged. Its
framers also intend REACH to support
and be consistent with other international
chemical agreements, such as the
Stockholm Convention on Persistent
Organic Pollutants, World Trade
Organization policies, and OECD chemi-
cal testing protocols. 
Testy about Testing
Testing is one of the REACH provisions
that provokes the most debate.
Registration documentation must include
information on a chemical’s intrinsic
properties, risks for human health and the
environment, anticipated uses, probable
exposure scenarios, risk management pro-
cedures, and a safety data sheet. Industry
balks at having to provide this complete
profile on every chemical, saying that
chemicals’ hazards should be weighed
against their benefits, and that if the risk
of exposure to the chemical is low, testing
standards need not be as thorough. 
Wolf-Rüdiger Bias, vice president for
regulatory affairs and product safety at
BASF, one of the world’s largest chemical
companies, estimates that it costs
US$448,000 to test a new chemical about
which nothing is known and that is manu-
factured at 10–100 metric tons a year. “This
would be much more than almost any sub-
stance in this volume range could earn in
the course of ten years,” Bias says, “and
would thus have a dramatic impact on a
company’s portfolio.” 
Industry is particularly concerned
about the status of intermediates (chemi-
cals that are used to produce other chemi-
cals and thus are not present per se in the
final products) and polymers (large, stable
molecules used in plastics and other com-
pounds) because inclusion of these classes
of chemicals would vastly increase the
number of chemicals to be tested. In its
present form, REACH exempts most
intermediates and polymers from most
testing requirements, but will require sim-
plified registration for some.
Despite the dearth of information
about chemicals’ biological effects, the
chemical industry insists that its products
are safe. “It’s not in the interest of any
company in the world, including the U.S.
companies, to come out with chemicals
that are known to be hazardous to the
public,” says Scévole de Cazotte, senior
director for European trade policy at the
U.S. Chamber of Commerce. “In reality,
companies already take precautionary
measures, including extensive testing of
their products, before they market them.”
He adds, “Now companies at their own
cost will bear alone the responsibility to
prove to the new European authorities
that their products are risk-free, rather
than manage the risks that are scientifical-
ly proven or likely. Certification by
bureaucrats does not make any substance
safer. It is the application of sound princi-
ples of risk management that does.”
The current extent of undisclosed test
data held by chemical companies is
unknown, because most chemical compa-
nies object to revealing their own data.
“We would not like to share proprietary
information with competitors, and it is
not easy to establish a system that ensures
that this information will be kept behind
closed doors,” says Bias.
But, counters Jim Willis, director of
the United Nations Environment
Programme’s Chemicals Programme,
“Nobody considers health and safety data
to be confidential information. If [indus-
try] has done the safety testing, they ought
to make it publicly available.” The
REACH proposal provides that nonpro-
prietary hazard and risk information from
registration documentation will be pub-
lished in a database maintained by the
newly established EU chemicals agency.
The chemical industry is concerned
about duplicative and incompatible test-
ing, but the REACH proposal states that
OECD standards will be applied. The
OECD developed a system known as
Mutual Acceptance of Data that Robert
Visser, director of the OECD’s Environ-
mental Health and Safety Division, says
avoids duplication of testing and nontariff
barriers to trade. One standard test per
end point, such as carcinogenicity or
biodegradation, is accepted among all
OECD members. Countries can ask for
more tests for other end points, but any
requested tests outside the standard
OECD battery will not be accepted by
other OECD countries.
Costs: How High the Moon?
A 7 May 2003 EC memo released with
the draft proposal, “Questions and
Answers on the New Chemicals Policy
REACH,” projected US$4.2 billion as the
“most likely” total direct cost to industry
of registration and testing, with indirect
costs to industry and “society as a whole”
of US$16–18 billion from inception to
2020. According to a January 2003
Worldwide Fund for Nature (WWF)
analysis of REACH, “A New Chemicals
Policy in Europe—New Opportunities for
Industry,” over REACH’s extended phase-
in period, industry’s worst-case estimate of
US$8.2 billion in costs would represent
about 0.1% of the European chemical
industry’s annual sales revenues.
Chemical control measures such as
REACH would also decrease chemical-
related health care costs. There have been
a few educated guesses as to the potential
savings. According to the EC white paper,
in 1999 the German Advisory Council on
the Environment estimated the annual
cost of allergies in Europe at US$34 bil-
lion. A recent study by Philip Landrigan,
director of the Center for Children’s
Health and the Environment at the
Mount Sinai School of Medicine in New
York City, and others, published in the
July 2002 EHP, calculated an annual
price tag of US$54.9 billion for pediatric
lead poisoning, asthma, childhood cancer,
and neurobehavioral disorders in the
United States. The researchers attribute
significant fractions of these diseases to
environmental toxicants. “Questions and
Answers on the New Chemicals Policy
REACH” estimates “likely occupational
health benefits” of US$21–63 billion over
a 30-year period. 
The chemical industry itself may find
that an ounce of prevention is worth a
pound of cure. Notes Mary Taylor, senior
research officer with the NGO Friends of
the Earth in the United Kingdom, “In the
long term we expect advances in science to
permit more precise identification of cause
and effect with respect to specific chemi-
cals and specific diseases, opening up the
prospect of increased litigation by affected
individuals and groups.” And the WWF
report suggests that the phrase “assessed
according to EU standards” could provide
a sort of seal of approval that might
encourage chemical users around the
world to buy EU chemicals. 
Critics say the combination of the
increased financial burden of testing, the
bureaucracy of registration and authoriza-
tion, and the requirement of applying the
precautionary principle will discourage
innovation and could ruin many small
and medium-sized enterprises, which are
often the most innovative companies. But
in its analysis of REACH, the WWF
argues that small and medium-sized
enterprises will survive because, whereas
the old system requires no testing of
grandfathered chemicals and thus dis-
courages innovation, REACH will level
the playing field by subjecting all chemi-
cals to the same standards for registration
and testing based on production volume.
Therefore, there is no longer an incentive
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centive to produce new, and possibly
greener, chemicals. REACH also provides
up to a 10-year period for research and
development before a substance must be
registered, and raises the threshold for
registration of new substances from the
current 10 kilograms per year to 1 metric
ton per year. Chemicals used in basic sci-
entific research and medical applications
are exempt altogether. 
Chemical Politics
The chemical industry supports the idea
of replacing the current arbitrary and
cumbersome system, but some industry
representatives think REACH goes too
far. “Initially the legislation was a very
good idea because it was rationalizing the
[regulation] process,” says de Cazotte.
“The idea was to simplify and market it
better based on available science.” But,
adds de Cazotte, environmental lobbyists
“hijacked” the concept by inserting lan-
guage requiring what industry views as
burdensome and expensive actions. 
Industry groups such as the European
Chemical Industry Council and the
American Chemistry Council (ACC), as
well as the U.S. Chamber of Commerce,
have mounted major lobbying campaigns
to ease REACH’s impact on business,
asserting that REACH would cause wide-
spread unemployment, deal a body blow
to the U.S. economy, and “deindustrial-
ize” Europe by forcing manufacturers into
the developing world. The ACC submit-
ted a formal critique of REACH during
the May–July online comment period,
which is posted on its website at
http://www.accnewsmedia.com/. The
ACC calls REACH “burdensome, costly,
and impractical.” The ACC did not
respond to repeated requests for an inter-
view for this article.
NGOs including the WWF, Friends
of the Earth, and Greenpeace, both indi-
vidually and through the umbrella
European Environmental Bureau—which
is accredited to have input into EU delib-
erations—argue that REACH, although a
major step forward in protecting human
and ecosystem health, has been diluted by
industry pressure. In this, they say, indus-
try has had a powerful friend in the U.S.
government.
The Bush administration has “tried
quite hard to slow REACH down,” says
Daryl Ditz, senior program officer for tox-
ics at the WWF. An 18 May 2003 article
in The New York Times reported that John
Graham, administrator of the Office of
Information and Regulatory Affairs, said
in a speech to EU regulators that the Bush
administration considers the precautionary
principle “to be a mythical concept [that
demands no serious consideration], per-
haps like a unicorn.” And a paper, “US
Intervention in EU Chemical Policy,”
issued in September by the Jamaica Plain,
New York–based NGO Environmental
Health Fund (EHF), charges that the
Bush administration has sought to weaken
REACH by inappropriate means. The
report calls for “a full congressional inves-
tigation into corporate influence over gov-
ernment actions.” 
The EHF report states that in March
2002,s Secretary of State Colin Powell cir-
culated the curiously titled “United States
Nonpaper on EU Chemicals Policy” to
U.S. embassies in EU member states, urg-
ing the embassies to distribute the docu-
ment to member states’ environment and
trade ministries. The “nonpaper” was
unsigned and printed on plain paper with-
out any U.S. government letterhead. It
said REACH could distort global markets
and violate World Trade Organization
principles, and that the precautionary
principle would result in “politically moti-
vated bans” of U.S. chemical products.
The EHF report found that parts of the
text closely resembled statements by the
ACC, and an article nearly identical to the
“nonpaper” appeared under the byline of
the U.S. Trade Representative in the June
2002 issue of the ACC magazine
Chemistry Business. 
According to an EPA official in the
Office of Pollution Prevention and
Toxics, who declined to speak for attribu-
tion, the EPA has “shared our experience
and approaches” with the U.S. Trade
Representative, the Department of State,
and the Department of Commerce, and
has met directly with REACH developers,
but the administration position has been
advanced mostly by those other agencies.
The EPA official says, “REACH, as pro-
posed, presents a potentially costly, bur-
densome, and pretty complex approach.
We have concerns about how workable it
will be in its implementation.” The
Department of Commerce did not
respond to requests for an interview about
the U.S. government’s position on
REACH. 
In late September it appeared that
industry and government pressure had
succeeded in changing the May 2003 draft
policy, to the dismay of green NGOs. A
revised draft was leaked to NGOs and
journalists, and although the EU would
not comment on it, an EU spokesperson
confirmed that an Environment Daily
report of 24 September 2003 was “factual-
ly correct.” That report said that under
the revised draft, downstream users of
chemicals will not be required to register
their products at all, and importers will
have to register their articles only if a
chemical is both classified as dangerous
and intended to be released in the prod-
uct; that the transparency of the registry
database has been obscured by a provision
of automatic anonymity for the registering
company; that polymers are almost entire-
ly exempt; and that below a production
level of 10 metric tons per year, no chem-
ical safety reports will be required. The
only change favorable to environmental-
ists is a slightly stronger emphasis on
encouraging—but not requiring—substi-
tution of a “greener” alternative for a
chemical that is required to undergo the
authorization process. 
Despite these changes, the ACC
found the revised draft to still be unac-
ceptable and issued a press release on 9
October 2003 saying REACH would
“create a confusing, wasteful, and ineffi-
cient bureaucracy.”
Reaching into the Future
Because of chemical reform’s momentum,
most stakeholders believe REACH will be
enacted in some form. A vote is not
expected before mid-2004, but before
then, elections will result in significant
changes in the makeup of both the EC
and the European Parliament. Moreover,
in May 2004, the EU’s membership will
jump from 15 to 25 nations with the
accession of Cyprus, the Czech Republic,
Estonia, Hungary, Latvia, Lithuania,
Malta, Poland, Slovakia, and Slovenia.
However, these changes are not expected
to radically affect REACH’s chances of
passage. Even so, it is impossible to pre-
dict exactly how REACH will emerge
from the political process. 
In a 16 May 2003 speech at the New
European Chemicals Policy Conference to
solicit comments on the REACH propos-
al, EU Environment Commissioner
Margot Wallström said, “A newborn baby
may have her father’s eyes and her moth-
er’s toes. But the child will also have a
cocktail of synthetic chemicals in his or
her bloodstream that have been ‘inherited’
from our modern way of life.” Given what
is already known about the few chemicals
whose biological harm has been identified,
it would be helpful to know what effect
that cocktail has on human health.
Whether the EU chooses to maintain the
status quo or build a new regulatory edi-
fice from the ground up, its decision will
reverberate around the world.
Valerie J. Brown
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